Tower Research Capital LLC (TRC) - SAB BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,412
-22.0%
14,940
+2.7%
0.00%
Q2 2023$12,072
+172357.1%
14,545
-9.4%
0.00%
Q1 2023$70.0%16,062
+40.8%
0.00%
Q4 2022$7
-99.9%
11,411
-16.4%
0.00%
Q3 2022$10,000
-16.7%
13,642
+66.9%
0.00%
Q2 2022$12,000
+71.4%
8,176
+372.3%
0.00%
Q1 2022$7,000
-41.7%
1,731
+10.6%
0.00%
Q4 2021$12,0001,5650.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
First PREMIER Bank 807,535$4760.14%
Warberg Asset Management LLC 370,370$218,5180.03%
METEORA CAPITAL, LLC 134,524$79,3560.02%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 149,774$88,3520.02%
SILVER OAK SECURITIES, Inc 51,941$310.01%
Veritable, L.P. 506,513$298,7920.01%
Shaolin Capital Management LLC 236,621$1400.00%
Elgethun Capital Management 14,796$9,1710.00%
LGL PARTNERS, LLC 23,000$13,5680.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$49,5520.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders